Debt-to-Equity Ratio

The debt-to-equity ratio measures how much a company relies on borrowed money relative to shareholder equity to finance its assets. It divides total liabilities by total shareholders' equity. A higher ratio means the company is more leveraged — more of its asset base is financed by debt than by equity.

This is one of the most widely used measures of financial risk because it captures the fundamental balance between what the company owes and what its shareholders own. A debt-to-equity ratio of 1.0 means liabilities and equity are equal. Above 1.0, the company has more debt than equity. Below 1.0, equity exceeds debt.

The acceptable range varies dramatically by industry. Utilities and REITs routinely operate with debt-to-equity ratios above 2.0 because their stable cash flows support higher leverage. Technology companies and consumer brands often have ratios below 0.5 because their business models are less capital-intensive. Banks and financial institutions have fundamentally different balance sheet structures and should not be compared to non-financial companies using this metric.

One important nuance: some highly profitable companies like Apple and Starbucks have negative equity due to aggressive share buyback programs that push accumulated deficit below zero. In those cases, the debt-to-equity ratio becomes mathematically meaningless (negative or extremely large) and should not be used as a risk indicator.

Debt-to-Equity Ratio = Total Liabilities / Total Shareholders' Equity

GeminIQ calculates debt-to-equity using total liabilities, so its values run higher than versions that count only borrowings. On that basis, the median for US companies with a market capitalization above $2 billion is 1.06, and the middle half fall between 0.48 and 2.18. About 26% are above 2.0, and about 6% have negative shareholders' equity, which makes the ratio meaningless.

Businesses with steady, predictable cash flows, such as utilities, retailers, and insurers, can carry more liabilities relative to equity. Insurers in particular sit high because policyholder reserves are liabilities. Research-driven companies such as pharmaceutical, biotech, and medical device makers, and most semiconductor firms, rely mainly on equity.

A reading above the industry range is worth investigating, but so is the trend: a ratio climbing year after year signals rising financial risk even when the level still looks ordinary. Large buybacks can also shrink equity and push the ratio up without any new borrowing. Figures are GeminIQ calculations across US companies that file with the SEC, using each company's latest reported period as of September 2026. The middle 50% runs from the 25th to the 75th percentile. The industry table groups companies by SIC code and includes those above $300 million in market capitalization.

GeminIQ uses Total Liabilities and Total Shareholders' Equity directly from the company's filed balance sheet. These are among the most commonly reclassified items during data normalization — aggregators may move minority interests, preferred equity, or certain hybrid instruments between liabilities and equity, which directly changes this ratio. GeminIQ preserves the company's as-filed classification.